Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
Dalmau
J
J
Peramiquel
L
L
Puig
L
L
Fernández-Figueras
M T
MT
Roé
E
E
Alomar
A
A
D017255:Acitretin / Q000627:therapeutic use*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D000068877:Imatinib Mesylate; D007641:Keratolytic Agents / Q000627:therapeutic use; D017512:Lichenoid Eruptions / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D007641:Keratolytic Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D017255:Acitretin